Skip to content
Use caution Drug recall · FDA · Published December 17, 2020

Fresenius Kabi Ketorolac Injection Recall: Particulate Matter Risk

Fresenius Kabi recalls Ketorol: 60mg/2mL injection vials due to particulate matter found in reserve samples. This may cause serious injury if injected.

🇺🇸 FDA recall #D-0184-2021DrugFresen: Kabi ›
Take action

Contact the company

Recalling firmFresenius Kabi USA, LLC3 Corporate Dr · Lake Zurich, IL 60047-8930
✎ GovInfoNow plain-language explainer

Fresenius Kabi is recalling Ketorolac injection vials that may contain particles. Using these vials could cause serious injury if injected. Read more at govinfonow.com/recall/36591-fresenius-kabi-ketorolac-injection-recall-particulate-matter-risk.

Source Summary by GovInfoNow · govinfonow.com/recall/36591-fresenius-kabi-ketorolac-injection-recall-particulate-matter-risk · Updated October 4, 2026 · FDA enforcement record: FDA #D-0184-2021

Cite this page

“Fresenius Kabi Ketorolac Injection Recall: Particulate Matter Risk.” GovInfoNow, updated October 4, 2026. https://govinfonow.com/recall/36591-fresenius-kabi-ketorolac-injection-recall-particulate-matter-risk. Based on FDA recall #D-0184-2021 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0184-2021%22&limit=1).

Fresenius Kabi USA, LLC voluntarily recalled Ketorolac Tromethamine Injection USP due to the presence of particulate matter in reserve sample vials, according to the FDA. The Food and Drug Administration announced the Class II recall on December 17, 2020.

How to tell if you have it

  • Brand: Fresen: Kabi
  • Product: Ketorolac Tromethamine Injection, USP, 60 mg per 2 mL (30 mg per mL), packaged in 2 mL Single Dose Vial, Rx only
  • NDC: 63323-162-02
  • Batch #: 6121125
  • Expiration: 02/2021

The hazard

The recall addresses the presence of particulate matter found in reserve sample vials at the firm, according to the FDA.

Context

GovInfoNow's records show Fresenius Kabi USA, LLC has 65 other recalls on record since September 27, 2012. Other recent recalls of similar products include Fresenius Kabi Tyenne Injection Recall (August 10, 2026), Fresen: Morphine Syringes May Have Wrong Labeling (August 4, 2026), and Fresenius Kabi Xylocaine 1% Injection Recall (July 16, 2026).

How to tell if you have this one

Check for vials labeled 'Ketorolac Tromethamine Injection, USP, 60 mg per 2 mL (30 mg per mL)' from Fresenius Kabi. The NDC code 63323-162-02 and batch number 6121125 are associated with this recall.

  • Brand
    Fresen: Kabi
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Vial Label

    Look for the product name and NDC code on the vial to confirm it matches the recalled items.

  2. Contact Healthcare Provider

    If you have the recalled vial, inform your healthcare provider immediately to discuss next steps.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFLPuerto Rico: yesPR

FDA distribution: “USA Nationwide and Puerto Rico” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 2.5 years after the firm started it.

1. Firm started the recall: Dec 17, 202012. FDA classified it Class II: Dec 31, 202023. Published in FDA’s Enforcement Report: Jan 6, 202134. FDA terminated the recall: Jun 20, 2023420202023
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

✎ GovInfoNow

Questions people ask

Is this product safe to use?

The recall indicates particulate matter was found in reserve samples, so it is not safe to use without checking the recall status.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0184-2021 (December 17, 2020) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0184-2021 to see it in context.
  • Plain-language summary written by qwen3:4b on October 4, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA